Funding Open access funding provided by Max Planck Society
BPC-157s angiogenic response has been described as more potent and consistent than standard angiogenic growth factors in comparative studies, and critically it functions without requiring special delivery systems or carriers, a significant limitation of most conventional growth factors
The abdomen, upper thigh, and upper arm are the three primary injection sites
For example, they might use 2.4 mg for 12 weeks, then reduce to 1.0 mg for 4 weeks, then return to 2.4 mg
Levels decline with age, contributing to: Slower recovery Reduced skin elasticity Increased oxidative stress
Because if you inject into the same spot again and again, it can cause changes and hardening of the skin texture